Novel Peptide Inhibitors for Lactate Dehydrogenase A (LDHA): A Survey to Inhibit LDHA Activity via Disruption of Protein-Protein Interaction

Lactate dehydrogenase A (LDHA) is a critical metabolic enzyme belonging to a family of 2-hydroxy acid oxidoreductases that plays a key role in anaerobic metabolism in the cells. In hypoxia condition, the overexpression of LDHA shifts the metabolic pathway of ATP synthesis from oxidative phosphorylat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2019-03, Vol.9 (1), p.4686-4686, Article 4686
Hauptverfasser: Jafary, Farzaneh, Ganjalikhany, Mohamad Reza, Moradi, Ali, Hemati, Mahdie, Jafari, Sepideh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4686
container_issue 1
container_start_page 4686
container_title Scientific reports
container_volume 9
creator Jafary, Farzaneh
Ganjalikhany, Mohamad Reza
Moradi, Ali
Hemati, Mahdie
Jafari, Sepideh
description Lactate dehydrogenase A (LDHA) is a critical metabolic enzyme belonging to a family of 2-hydroxy acid oxidoreductases that plays a key role in anaerobic metabolism in the cells. In hypoxia condition, the overexpression of LDHA shifts the metabolic pathway of ATP synthesis from oxidative phosphorylation to aerobic glycolysis and the hypoxia condition is a common phenomenon occurred in the microenvironment of tumor cells; therefore, the inhibition of LDHA is considered to be an excellent strategy for cancer therapy. In this study, we employed in silico methods to design inhibitory peptides for lactate dehydrogenase through the disturbance in tetramerization of the enzyme. Using peptide as an anti-cancer agent is a novel approach for cancer therapy possessing some advantages with respect to the chemotherapeutic drugs such as low toxicity, ease of synthesis, and high target specificity. So peptides can act as appropriate enzyme inhibitor in parallel to chemical compounds. In this study, several computational techniques such as molecular dynamics (MD) simulation, docking and MM-PBSA calculation have been employed to investigate the structural characteristics of the monomer, dimer, and tetramer forms of the enzyme. Analysis of MD simulation and protein-protein interaction showed that the N-terminal arms of each subunit have an important role in enzyme tetramerization to establish active form of the enzyme. Hence, N-terminal arm can be used as a template for peptide design. Then, peptides were designed and evaluated to obtain best binders based on the affinity and physicochemical properties. Finally, the inhibitory effect of the peptides on subunit association was measured by dynamic light scattering (DLS) technique. Our results showed that the designed peptides which mimic the N-terminal arm of the enzyme can successfully target the C-terminal domain and interrupt the bona fide form of the enzyme subunits. The result of this study makes a new avenue to disrupt the assembly process and thereby oppress the function of the LDHA.
doi_str_mv 10.1038/s41598-019-38854-7
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6423238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2194135913</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-207d9223d6d714c6e144bf616e95faab5690f83e26b0050ea597d74183f622663</originalsourceid><addsrcrecordid>eNp9Uc1u1DAQjhAVrdq-AAdkiUt7CPV_bA5Iqy7QSiuoBJwtJ5nsusrGi-1E2nfgofGy29JywJcZ6fsZz3xF8ZrgdwQzdRU5EVqVmOiSKSV4Wb0oTijmoqSM0pdP-uPiPMZ7nJ-gmhP9qjhmWClJRHVS_PriJ-jRHWySawHdDitXu-RDRJ0PaGGbZBOgOay2bfBLGGwENEMXi_nN7PJ97r6NYYItSv5BinYQmjXJTS5t0eQsmrsYxuzvB-Q7dBd8AjeUh5p1CUKek-Gz4qizfYTzQz0tfnz6-P36plx8_Xx7PVuUjSAklRRXraaUtbKtCG8kEM7rThIJWnTW1kJq3CkGVNZ5ZwxW6KqtOFGsk5RKyU6LD3vfzVivoW1gSMH2ZhPc2oat8daZ58jgVmbpJyN5PihT2eDiYBD8zxFiMmsXG-h7O4Afo6EkH5oJTVimvv2Heu_HMOT1diwmuZRkZ0j3rCb4GAN0j58h2OzyNvu8Tc7b_MnbVFn05ukaj5KHdDOB7QkxQ8MSwt_Z_7H9DbuztZ8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2193646618</pqid></control><display><type>article</type><title>Novel Peptide Inhibitors for Lactate Dehydrogenase A (LDHA): A Survey to Inhibit LDHA Activity via Disruption of Protein-Protein Interaction</title><source>Nature Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Jafary, Farzaneh ; Ganjalikhany, Mohamad Reza ; Moradi, Ali ; Hemati, Mahdie ; Jafari, Sepideh</creator><creatorcontrib>Jafary, Farzaneh ; Ganjalikhany, Mohamad Reza ; Moradi, Ali ; Hemati, Mahdie ; Jafari, Sepideh</creatorcontrib><description>Lactate dehydrogenase A (LDHA) is a critical metabolic enzyme belonging to a family of 2-hydroxy acid oxidoreductases that plays a key role in anaerobic metabolism in the cells. In hypoxia condition, the overexpression of LDHA shifts the metabolic pathway of ATP synthesis from oxidative phosphorylation to aerobic glycolysis and the hypoxia condition is a common phenomenon occurred in the microenvironment of tumor cells; therefore, the inhibition of LDHA is considered to be an excellent strategy for cancer therapy. In this study, we employed in silico methods to design inhibitory peptides for lactate dehydrogenase through the disturbance in tetramerization of the enzyme. Using peptide as an anti-cancer agent is a novel approach for cancer therapy possessing some advantages with respect to the chemotherapeutic drugs such as low toxicity, ease of synthesis, and high target specificity. So peptides can act as appropriate enzyme inhibitor in parallel to chemical compounds. In this study, several computational techniques such as molecular dynamics (MD) simulation, docking and MM-PBSA calculation have been employed to investigate the structural characteristics of the monomer, dimer, and tetramer forms of the enzyme. Analysis of MD simulation and protein-protein interaction showed that the N-terminal arms of each subunit have an important role in enzyme tetramerization to establish active form of the enzyme. Hence, N-terminal arm can be used as a template for peptide design. Then, peptides were designed and evaluated to obtain best binders based on the affinity and physicochemical properties. Finally, the inhibitory effect of the peptides on subunit association was measured by dynamic light scattering (DLS) technique. Our results showed that the designed peptides which mimic the N-terminal arm of the enzyme can successfully target the C-terminal domain and interrupt the bona fide form of the enzyme subunits. The result of this study makes a new avenue to disrupt the assembly process and thereby oppress the function of the LDHA.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-019-38854-7</identifier><identifier>PMID: 30886157</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/114 ; 631/45/607 ; 631/45/611 ; Adenosine Triphosphate - metabolism ; Binders ; Cancer ; Cancer therapies ; Computer applications ; Dehydrogenase ; Dehydrogenases ; Design ; Enzyme inhibitors ; Enzymes ; Glycolysis ; Humanities and Social Sciences ; Humans ; Hypoxia ; Hypoxia - metabolism ; Hypoxia - pathology ; L-Lactate dehydrogenase ; Lactate Dehydrogenase 5 - antagonists &amp; inhibitors ; Lactate Dehydrogenase 5 - genetics ; Lactate Dehydrogenase 5 - metabolism ; Lactic acid ; Light scattering ; Metabolism ; Molecular dynamics ; Molecular Dynamics Simulation ; Molecular Mimicry ; Molecular Targeted Therapy ; multidisciplinary ; Neoplasms - metabolism ; Neoplasms - pathology ; Oxidative Phosphorylation ; Peptide inhibitors ; Peptides ; Peptides - pharmacology ; Phosphorylation ; Physicochemical properties ; Protein Binding ; Protein interaction ; Protein Interaction Domains and Motifs - genetics ; Proteins ; Science ; Science (multidisciplinary) ; Surveys and Questionnaires ; Toxicity ; Tumor cells</subject><ispartof>Scientific reports, 2019-03, Vol.9 (1), p.4686-4686, Article 4686</ispartof><rights>The Author(s) 2019</rights><rights>This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-207d9223d6d714c6e144bf616e95faab5690f83e26b0050ea597d74183f622663</citedby><cites>FETCH-LOGICAL-c511t-207d9223d6d714c6e144bf616e95faab5690f83e26b0050ea597d74183f622663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423238/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423238/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,41120,42189,51576,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30886157$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jafary, Farzaneh</creatorcontrib><creatorcontrib>Ganjalikhany, Mohamad Reza</creatorcontrib><creatorcontrib>Moradi, Ali</creatorcontrib><creatorcontrib>Hemati, Mahdie</creatorcontrib><creatorcontrib>Jafari, Sepideh</creatorcontrib><title>Novel Peptide Inhibitors for Lactate Dehydrogenase A (LDHA): A Survey to Inhibit LDHA Activity via Disruption of Protein-Protein Interaction</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Lactate dehydrogenase A (LDHA) is a critical metabolic enzyme belonging to a family of 2-hydroxy acid oxidoreductases that plays a key role in anaerobic metabolism in the cells. In hypoxia condition, the overexpression of LDHA shifts the metabolic pathway of ATP synthesis from oxidative phosphorylation to aerobic glycolysis and the hypoxia condition is a common phenomenon occurred in the microenvironment of tumor cells; therefore, the inhibition of LDHA is considered to be an excellent strategy for cancer therapy. In this study, we employed in silico methods to design inhibitory peptides for lactate dehydrogenase through the disturbance in tetramerization of the enzyme. Using peptide as an anti-cancer agent is a novel approach for cancer therapy possessing some advantages with respect to the chemotherapeutic drugs such as low toxicity, ease of synthesis, and high target specificity. So peptides can act as appropriate enzyme inhibitor in parallel to chemical compounds. In this study, several computational techniques such as molecular dynamics (MD) simulation, docking and MM-PBSA calculation have been employed to investigate the structural characteristics of the monomer, dimer, and tetramer forms of the enzyme. Analysis of MD simulation and protein-protein interaction showed that the N-terminal arms of each subunit have an important role in enzyme tetramerization to establish active form of the enzyme. Hence, N-terminal arm can be used as a template for peptide design. Then, peptides were designed and evaluated to obtain best binders based on the affinity and physicochemical properties. Finally, the inhibitory effect of the peptides on subunit association was measured by dynamic light scattering (DLS) technique. Our results showed that the designed peptides which mimic the N-terminal arm of the enzyme can successfully target the C-terminal domain and interrupt the bona fide form of the enzyme subunits. The result of this study makes a new avenue to disrupt the assembly process and thereby oppress the function of the LDHA.</description><subject>631/114</subject><subject>631/45/607</subject><subject>631/45/611</subject><subject>Adenosine Triphosphate - metabolism</subject><subject>Binders</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Computer applications</subject><subject>Dehydrogenase</subject><subject>Dehydrogenases</subject><subject>Design</subject><subject>Enzyme inhibitors</subject><subject>Enzymes</subject><subject>Glycolysis</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Hypoxia - metabolism</subject><subject>Hypoxia - pathology</subject><subject>L-Lactate dehydrogenase</subject><subject>Lactate Dehydrogenase 5 - antagonists &amp; inhibitors</subject><subject>Lactate Dehydrogenase 5 - genetics</subject><subject>Lactate Dehydrogenase 5 - metabolism</subject><subject>Lactic acid</subject><subject>Light scattering</subject><subject>Metabolism</subject><subject>Molecular dynamics</subject><subject>Molecular Dynamics Simulation</subject><subject>Molecular Mimicry</subject><subject>Molecular Targeted Therapy</subject><subject>multidisciplinary</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Oxidative Phosphorylation</subject><subject>Peptide inhibitors</subject><subject>Peptides</subject><subject>Peptides - pharmacology</subject><subject>Phosphorylation</subject><subject>Physicochemical properties</subject><subject>Protein Binding</subject><subject>Protein interaction</subject><subject>Protein Interaction Domains and Motifs - genetics</subject><subject>Proteins</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Surveys and Questionnaires</subject><subject>Toxicity</subject><subject>Tumor cells</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9Uc1u1DAQjhAVrdq-AAdkiUt7CPV_bA5Iqy7QSiuoBJwtJ5nsusrGi-1E2nfgofGy29JywJcZ6fsZz3xF8ZrgdwQzdRU5EVqVmOiSKSV4Wb0oTijmoqSM0pdP-uPiPMZ7nJ-gmhP9qjhmWClJRHVS_PriJ-jRHWySawHdDitXu-RDRJ0PaGGbZBOgOay2bfBLGGwENEMXi_nN7PJ97r6NYYItSv5BinYQmjXJTS5t0eQsmrsYxuzvB-Q7dBd8AjeUh5p1CUKek-Gz4qizfYTzQz0tfnz6-P36plx8_Xx7PVuUjSAklRRXraaUtbKtCG8kEM7rThIJWnTW1kJq3CkGVNZ5ZwxW6KqtOFGsk5RKyU6LD3vfzVivoW1gSMH2ZhPc2oat8daZ58jgVmbpJyN5PihT2eDiYBD8zxFiMmsXG-h7O4Afo6EkH5oJTVimvv2Heu_HMOT1diwmuZRkZ0j3rCb4GAN0j58h2OzyNvu8Tc7b_MnbVFn05ukaj5KHdDOB7QkxQ8MSwt_Z_7H9DbuztZ8</recordid><startdate>20190318</startdate><enddate>20190318</enddate><creator>Jafary, Farzaneh</creator><creator>Ganjalikhany, Mohamad Reza</creator><creator>Moradi, Ali</creator><creator>Hemati, Mahdie</creator><creator>Jafari, Sepideh</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190318</creationdate><title>Novel Peptide Inhibitors for Lactate Dehydrogenase A (LDHA): A Survey to Inhibit LDHA Activity via Disruption of Protein-Protein Interaction</title><author>Jafary, Farzaneh ; Ganjalikhany, Mohamad Reza ; Moradi, Ali ; Hemati, Mahdie ; Jafari, Sepideh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-207d9223d6d714c6e144bf616e95faab5690f83e26b0050ea597d74183f622663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>631/114</topic><topic>631/45/607</topic><topic>631/45/611</topic><topic>Adenosine Triphosphate - metabolism</topic><topic>Binders</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Computer applications</topic><topic>Dehydrogenase</topic><topic>Dehydrogenases</topic><topic>Design</topic><topic>Enzyme inhibitors</topic><topic>Enzymes</topic><topic>Glycolysis</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Hypoxia - metabolism</topic><topic>Hypoxia - pathology</topic><topic>L-Lactate dehydrogenase</topic><topic>Lactate Dehydrogenase 5 - antagonists &amp; inhibitors</topic><topic>Lactate Dehydrogenase 5 - genetics</topic><topic>Lactate Dehydrogenase 5 - metabolism</topic><topic>Lactic acid</topic><topic>Light scattering</topic><topic>Metabolism</topic><topic>Molecular dynamics</topic><topic>Molecular Dynamics Simulation</topic><topic>Molecular Mimicry</topic><topic>Molecular Targeted Therapy</topic><topic>multidisciplinary</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Oxidative Phosphorylation</topic><topic>Peptide inhibitors</topic><topic>Peptides</topic><topic>Peptides - pharmacology</topic><topic>Phosphorylation</topic><topic>Physicochemical properties</topic><topic>Protein Binding</topic><topic>Protein interaction</topic><topic>Protein Interaction Domains and Motifs - genetics</topic><topic>Proteins</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Surveys and Questionnaires</topic><topic>Toxicity</topic><topic>Tumor cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jafary, Farzaneh</creatorcontrib><creatorcontrib>Ganjalikhany, Mohamad Reza</creatorcontrib><creatorcontrib>Moradi, Ali</creatorcontrib><creatorcontrib>Hemati, Mahdie</creatorcontrib><creatorcontrib>Jafari, Sepideh</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jafary, Farzaneh</au><au>Ganjalikhany, Mohamad Reza</au><au>Moradi, Ali</au><au>Hemati, Mahdie</au><au>Jafari, Sepideh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Peptide Inhibitors for Lactate Dehydrogenase A (LDHA): A Survey to Inhibit LDHA Activity via Disruption of Protein-Protein Interaction</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2019-03-18</date><risdate>2019</risdate><volume>9</volume><issue>1</issue><spage>4686</spage><epage>4686</epage><pages>4686-4686</pages><artnum>4686</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Lactate dehydrogenase A (LDHA) is a critical metabolic enzyme belonging to a family of 2-hydroxy acid oxidoreductases that plays a key role in anaerobic metabolism in the cells. In hypoxia condition, the overexpression of LDHA shifts the metabolic pathway of ATP synthesis from oxidative phosphorylation to aerobic glycolysis and the hypoxia condition is a common phenomenon occurred in the microenvironment of tumor cells; therefore, the inhibition of LDHA is considered to be an excellent strategy for cancer therapy. In this study, we employed in silico methods to design inhibitory peptides for lactate dehydrogenase through the disturbance in tetramerization of the enzyme. Using peptide as an anti-cancer agent is a novel approach for cancer therapy possessing some advantages with respect to the chemotherapeutic drugs such as low toxicity, ease of synthesis, and high target specificity. So peptides can act as appropriate enzyme inhibitor in parallel to chemical compounds. In this study, several computational techniques such as molecular dynamics (MD) simulation, docking and MM-PBSA calculation have been employed to investigate the structural characteristics of the monomer, dimer, and tetramer forms of the enzyme. Analysis of MD simulation and protein-protein interaction showed that the N-terminal arms of each subunit have an important role in enzyme tetramerization to establish active form of the enzyme. Hence, N-terminal arm can be used as a template for peptide design. Then, peptides were designed and evaluated to obtain best binders based on the affinity and physicochemical properties. Finally, the inhibitory effect of the peptides on subunit association was measured by dynamic light scattering (DLS) technique. Our results showed that the designed peptides which mimic the N-terminal arm of the enzyme can successfully target the C-terminal domain and interrupt the bona fide form of the enzyme subunits. The result of this study makes a new avenue to disrupt the assembly process and thereby oppress the function of the LDHA.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>30886157</pmid><doi>10.1038/s41598-019-38854-7</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2019-03, Vol.9 (1), p.4686-4686, Article 4686
issn 2045-2322
2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6423238
source Nature Open Access; MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Springer Nature OA/Free Journals; Free Full-Text Journals in Chemistry
subjects 631/114
631/45/607
631/45/611
Adenosine Triphosphate - metabolism
Binders
Cancer
Cancer therapies
Computer applications
Dehydrogenase
Dehydrogenases
Design
Enzyme inhibitors
Enzymes
Glycolysis
Humanities and Social Sciences
Humans
Hypoxia
Hypoxia - metabolism
Hypoxia - pathology
L-Lactate dehydrogenase
Lactate Dehydrogenase 5 - antagonists & inhibitors
Lactate Dehydrogenase 5 - genetics
Lactate Dehydrogenase 5 - metabolism
Lactic acid
Light scattering
Metabolism
Molecular dynamics
Molecular Dynamics Simulation
Molecular Mimicry
Molecular Targeted Therapy
multidisciplinary
Neoplasms - metabolism
Neoplasms - pathology
Oxidative Phosphorylation
Peptide inhibitors
Peptides
Peptides - pharmacology
Phosphorylation
Physicochemical properties
Protein Binding
Protein interaction
Protein Interaction Domains and Motifs - genetics
Proteins
Science
Science (multidisciplinary)
Surveys and Questionnaires
Toxicity
Tumor cells
title Novel Peptide Inhibitors for Lactate Dehydrogenase A (LDHA): A Survey to Inhibit LDHA Activity via Disruption of Protein-Protein Interaction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T17%3A49%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Peptide%20Inhibitors%20for%20Lactate%20Dehydrogenase%20A%20(LDHA):%20A%20Survey%20to%20Inhibit%20LDHA%20Activity%20via%20Disruption%20of%20Protein-Protein%20Interaction&rft.jtitle=Scientific%20reports&rft.au=Jafary,%20Farzaneh&rft.date=2019-03-18&rft.volume=9&rft.issue=1&rft.spage=4686&rft.epage=4686&rft.pages=4686-4686&rft.artnum=4686&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-019-38854-7&rft_dat=%3Cproquest_pubme%3E2194135913%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2193646618&rft_id=info:pmid/30886157&rfr_iscdi=true